Kwang Dong Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kwang Dong Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Hanmi Pharmaceutical., Company Limited
sales of 882.72 billion Korean Won [US$794.45 million]
of which 77%
Daewoong Company Limited
(1.02 trillion Korean Won [US$913.51 million]
of which 114%
was Medicinal Manufacturing & Selling), and
Daewoong Pharmaceutical Company Limited
(883.92 billion Korean Won [US$795.53 million]
of which 100%
was Medicine Manufacture&Sale).
During the year ended December of 2016, sales at
Kwang Dong Pharmaceutical Company Limited were 1.06 trillion Korean Won (US$950.79 million).
increase of 10.6%
versus 2015, when the company's sales were 955.45 billion Korean Won.
This was the fifth consecutive year of sales increases at Kwang Dong Pharmaceutical Company Limited
(and since 2011, sales have increased a total of 236%).
Sales of Pharmacy Operations saw an increase
that was more than double the company's growth rate: sales were up
21.6% in 2016, from
165.09 billion Korean Won to 200.79 billion Korean Won.